Sam Brusco, Associate Editor05.23.23
Molecular diagnostics company Cepheid has appointed Vitor Rocha as its new president.
Rocha previously spent 12 years at Philips where he served as CEO of Philips North America, and CEO of the company’s global ultrasound business. Prior to Philips, Rocha worked at GE Healthcare for over a decade in many leadership roles, including management of sales operations across 32 countries.
"Vitor brings a proven track record of more than 20 years' experience as a global leader in the medical devices industry along with a passion for patient care to his new role at Cepheid" Joakim Weidemanis, executive VP, Danaher Diagnostics Platform, told the press. "This is an exciting time to be involved in the diagnostics industry and we welcome Vitor to Cepheid's executive leadership team."
Rocha was born and raised in Brazil, where he experienced the challenges of access to healthcare.
"I am honored to have the opportunity to lead a team with a legacy of innovating accurate and timely PCR testing to advance global public health," Rocha said. "Cepheid shares my passion for improving the overall experience for healthcare professionals and patients globally."
Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics.
Rocha previously spent 12 years at Philips where he served as CEO of Philips North America, and CEO of the company’s global ultrasound business. Prior to Philips, Rocha worked at GE Healthcare for over a decade in many leadership roles, including management of sales operations across 32 countries.
"Vitor brings a proven track record of more than 20 years' experience as a global leader in the medical devices industry along with a passion for patient care to his new role at Cepheid" Joakim Weidemanis, executive VP, Danaher Diagnostics Platform, told the press. "This is an exciting time to be involved in the diagnostics industry and we welcome Vitor to Cepheid's executive leadership team."
Rocha was born and raised in Brazil, where he experienced the challenges of access to healthcare.
"I am honored to have the opportunity to lead a team with a legacy of innovating accurate and timely PCR testing to advance global public health," Rocha said. "Cepheid shares my passion for improving the overall experience for healthcare professionals and patients globally."
Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics.